Cancer researchers at Tampa General Hospital and Moffitt Cancer Center are optimistic about breakthroughs in medicine, treatments, immunotherapies, and mRNA vaccines to treat some cancers.
/PRNewswire/ Tampa General Hospital is announcing its appointment of Dr. Ivan Borrello to the TGH Cancer Institute. Borrello is a world-class translational.
WindMIL Therapeutics Appoints Dr. Kimberly Noonan as Chief Science & Technology Officer
May 06, 2021 07:00 ET | Source: WindMIL Therapeutics WindMIL Therapeutics Philadelphia, Pennsylvania, UNITED STATES
PHILADELPHIA and BALTIMORE, May 06, 2021 (GLOBE NEWSWIRE) WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs
®) for cancer immunotherapy, today announced the appointment of Co-Founder Kimberly Noonan, PhD, MPH, to Executive Vice President, Chief Science & Technology Officer. In this role, Dr. Noonan’s leadership will expand to include WindMIL’s efforts in manufacturing and manufacturing science and technology (MS&T).
“As we continue to build momentum developing MILs as a novel class of autologous cell therapies for cancer immunotherapy, we are delighted to broaden Dr. Noonan’s role at WindMIL,” said Don Hayden, Chairman and Chief Executive Officer of WindMIL Therapeutic